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ABSTRACT: Previously we have shown that liquid extraction surface analysis (LESA)
mass spectrometry is suitable for the analysis of intact proteins from a range of
biological substrates. Here we show that LESA mass spectrometry may be coupled
with high ﬁeld asymmetric waveform ion mobility spectrometry (FAIMS) for top-
down protein analysis directly from thin tissue sections (mouse liver, mouse brain) and
from bacterial colonies (Escherichia coli) growing on agar. Incorporation of FAIMS
results in signiﬁcant improvements in signal-to-noise and reduced analysis time.
Abundant protein signals are observed in single scan mass spectra. In addition, FAIMS
enables gas-phase separation of molecular classes, for example, lipids and proteins,
enabling improved analysis of both sets of species from a single LESA extraction.
Liquid extraction surface analysis (LESA)1 mass spectrom-etry is emerging as a powerful tool for in situ analysis of
intact proteins. In LESA, a robotic pipet dispenses a droplet (a
few μL) of solvent onto the surface under investigation. The
droplet is held in contact between the pipet and the surface for
a few seconds, that is, a liquid microjunction is maintained, and
soluble analytes are extracted. The sample droplet is reaspirated
and introduced into the mass spectrometer via electrospray
ionization. Edwards et al. demonstrated that the approach,
which is also known as liquid microjunction sampling, could be
applied to the analysis of hemoglobin variants from neonatal
dried blood spots.2−4 Schey et al. demonstrated manual LESA
of intact proteins from thin tissue sections of mouse brain and
kidney, and bovine ocular lens.5 Sarsby et al. applied LESA
mass spectrometry for the analysis of intact protein biomarkers
of nonalcoholic liver disease.6 More recently, we have shown
that a variation of LESA, which we termed “contact” LESA
allows top-down analysis of proteins from living bacterial
colonies7 and intact protein complexes.8
Challenges for top-down protein analysis by LESA mass
spectrometry include those faced in any top-down electrospray
analysis−the requirement for high resolution mass spectrom-
etry, the presence of multiple charge states (for both precursor
and fragment ions), the large number of fragmentation
channels available. These challenges are compounded in
LESA mass spectrometry by the potential complexity of the
sample, particularly for biological substrates. Multiple proteins
and proteoforms may be present over a wide dynamic range. In
addition, the presence of other molecular classes, for example,
lipids, may cause interference as a result of ion suppression. To
date, LESA MS of proteins tends to involve collection and
coadding of multiple scans in order to obtain suﬃcient S/N for
peak detection. This feature could present a barrier to the
adoption of LESA MS for imaging of intact proteins. A
potential solution to the issue of sample complexity is the
coupling of liquid-phase separation methods; however, this
brings a signiﬁcant time cost. A typical HPLC MS analysis takes
∼1 h,5 clearly incompatible with fast acquisition of a LESA
image even of relatively few pixels. In contrast, the gas-phase
separation aﬀorded by ion mobility spectrometry, which
separates ions on the basis of shape and charge, can be
achieved on the order of milliseconds.
High-ﬁeld asymmetric waveform ion mobility spectrometry
(FAIMS), also known as diﬀerential ion mobility spectrometry,
oﬀers several advantages for the analysis of peptides and
proteins, including reduced chemical noise, improved S/N,9−12
and separation of peptide isomers.13−16 FAIMS separates gas-
phase ions at atmospheric pressure on the basis of diﬀerences in
the ion mobilities in high and low electric ﬁelds.17,18 Ions are
passed between two parallel electrodes by a carrier gas. An
asymmetric waveform is applied to the electrodes to provide
alternating high and low electric ﬁelds perpendicular to the
direction of the ions’ trajectory through the device. The high
electric ﬁeld is designated the dispersion ﬁeld (DF). As a result
of the diﬀerences in mobilities in high and low electric ﬁelds,
the ions will deviate from their original trajectory toward one of
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the electrodes. If uncorrected, they will collide with the
electrode. Superposition of a compensation ﬁeld (CF) prevents
this occurrence. By tuning the compensation ﬁeld, it is possible
to selectively transmit ions of a particular diﬀerential mobility.
FAIMS devices have previously been coupled to ambient
ionization techniques for the analysis of small molecules.
Fernandez and co-workers coupled desorption electrospray
(DESI) with FAIMS for the analysis of counterfeit
pharmaceuticals.19 More recently, they demonstrated DESI
FAIMS mass spectrometry for the imaging of phosphatidylcho-
lines (m/z 700−900) in rat brain tissue.20 Manicke and Belford
coupled paperspray ionization with FAIMS for the separation
of isomeric drug compounds.21 Porta and co-workers have
shown that LESA coupled with FAIMS is suitable for the
analysis of drugs of abuse and their metabolites.22 In that work,
a prototype FAIMS device was coupled with a triple
quadrupole linear ion trap mass spectrometer.
Here, we demonstrate the beneﬁts of FAIMS for intact and
top-down protein analysis by LESA mass spectrometry. We
have coupled LESA with a miniaturized chip-based FAIMS
device23 and a high resolution orbitrap mass spectrometer.
LESA FAIMS analyses were performed on thin tissue sections
from mouse liver and mouse brain and on E. coli colonies
growing on agar (Note, the analysis of bacteria made use of the
“contact” LESA approach described in ref 7). The results show
signiﬁcant improvements in protein peak S/N, enabling
detection of proteins in single scan mass spectra (i.e., in
under 2 s, compared with several minutes required in the
absence of FAIMS). Moreover, it is possible to separate
molecular classes such that diﬀerent species may be analyzed
from a single LESA extraction. That is, FAIMS addresses the
inherent challenge of sample complexity in LESA MS of
biological substrates.
■ EXPERIMENTAL SECTION
Materials. Thin Tissue Sections. Liver and brain from wild-
type mice (extraneous tissue from culled animals) were the gift
of Prof. Steve Watson (University of Birmingham). Organs
were frozen on dry ice prior to storage at −80 °C. Sections of
murine liver tissue and brain tissue of area ∼1.5 cm2 were
obtained at a thickness of 10 μm using a CM1810 Cryostat
(Leica Microsystmes, Wetzlar, Germany) and thaw mounted
onto glass slides.
E. coli Colonies. A strain of Escherichia coli K-12 was
inoculated onto solid LBA medium (LB 20 g L-1 Agar 20 g L-
1) in 6 cm diameter Petri dishes. Samples were incubated at 37
°C for ∼12 h and subsequently stored in the dark at 4 °C until
analysis (∼43 days).
Solvents. The following solvents were used: acetonitrile (J.
T. Baker, The Netherlands), methanol (J. T. Baker, The
Netherlands), ethanol (Fisher Scientiﬁc, Loughborough, U.K.),
HPLC grade water (J. T. Baker, The Netherlands), and formic
acid (Sigma-Aldrich Company Ltd., Dorset, U.K.).
Peptide and Protein Standards (for direct infusion
electrospray). A solution comprising AAAAAAnYK (2 μM;
nY = nitrotyrosine; AltaBioscience, Birmingham, U.K.) and
angiotensin I (2 μM), substance P (2 μM), bovine ubiquitin (5
μM), and hemoglobin S (5 μM) (all Sigma-Aldrich, Dorset,
U.K.) was prepared in 69.5:29.5:1 methanol/water/formic acid.
Liquid Extraction Surface Analysis. Thin tissue section
samples were loaded onto a universal LESA adapter plate and
placed in the TriVersa Nanomate chip-based electrospray
device (Advion, Ithaca, NY) coupled to the Thermo Fisher
Scientiﬁc Orbitrap Velos or Elite (Thermo Fisher Scientiﬁc,
Bremen, Germany). Bacteria samples were placed directly in
the Triversa Nanomate (see ref 7 for details).
Thin Tissue Sections. The solvent system used for LESA
extraction/electrospray was 69.5:29.5:1 methanol/water/formic
acid (mouse liver) or 39.5:59.5:1 acetonitrile/water/formic acid
(mouse brain). Brain sections were prewashed by LESA
sampling with 80:20 ethanol/water. Wash solutions were
dispensed to waste. A total of 6 μL were aspirated from the
solvent well. The robotic arm relocated to a position above the
tissue and descended to a height 0.2 mm above the surface of
the sample. A total of 3 μL of the solution was dispensed onto
the sample surface to form a liquid microjunction. The liquid
microjunction was maintained for 10 s; then 3.5 μL were
reaspirated into the pipet tip.
E. coli. The solvent system used for LESA extraction/
electrospray was 39.5:59.5:1 acetonitrile/water/formic acid.
Three μL were aspirated from the solvent well. The robotic arm
relocated to a position above the bacterial colony and
descended until in contact with the surface of the bacterial
colony. A total of 2 μL of the solution was dispensed onto the
sample surface to form a liquid microjunction. The liquid
microjunction was maintained with the surface for 3 s; then 2.5
μL were reaspirated into the pipet tip.
Samples were introduced into the mass spectrometer via the
TriVersa NanoMate, with gas pressure 0.3 psi, a tip voltage of
1.75 kV (or 1.55 kV for direct infusion electrospray), and a
capillary temperature of 250 °C.
UltraFAIMS. The Triversa Nanomate was coupled to a
miniaturized ultra-FAIMS device (Owlstone, Cambridge, U.K.),
which was coupled to an Orbitrap Velos or Orbitrap Elite mass
spectrometer (Thermo Fisher Scientiﬁc, Bremen Germany),
see Supporting Information, Figure 1. FAIMS separation was
carried out in positive ion mode using a microchip device
(Owlstone).24 The FAIMS device was operated either in 2D
mode or in static mode.
2-D FAIMS Analyses. FAIMS separation was carried out at
eight discrete dispersion ﬁelds (DFs) between 130 and 270 Td
with a step size of 20 Td. At each DF, the compensation ﬁeld
was varied between −1 to +4 Td (step size 2.5 mTd) over a
time period of 180 s.
Static FAIMS Analyses. Optimal DF and CF conditions for
the transmission of ions of interest were selected from the 2D
FAIMS analyses. Data shown were recorded as follows: Mouse
Liver: DF = 130 Td, CF = 0.30 Td. Mouse brain: DF = 270 Td,
CF = 2.60 Td. E. coli: DF = 210 Td, CF = 1.65 Td.
Mass Spectrometry. The majority of mass spectrometry
experiments were performed on a Thermo Fisher Orbitrap
Velos. Results shown for the 2D FAIMS analysis of mouse
brain sections were recorded on a Thermo Fisher Orbitrap
Elite.
Mass spectra were collected in full scan mode (m/z 400−
2000 (mouse samples); m/z 500−2000 (E. coli samples)) at a
resolving power of 100000 at m/z 400 (Orbitrap Velos) or
120000 (Orbitrap Elite) at m/z 200. The AGC target was 1 ×
106 charges with a maximum injection time of 1000 ms. Each
scan was composed of 1 microscan.
Tandem Mass Spectrometry. CID: CID was carried out in
the linear ion trap at normalized collision energy of 30%, and
fragment ions were detected in the orbitrap at a resolving
power of 100000 at m/z 400. AGC target was 1 × 106 (mouse
tissue samples) or 1 × 105 (E. coli samples) with maximum
injection time of 1 s. HCD: HCD experiments (NCE 30%)
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were recorded at a resolving power of 100000 at m/z 400. AGC
target was 1 × 106 (mouse tissue samples) or 1 × 105 (E. coli
samples) with maximum injection time of 1 s. ETD: ETD was
performed with ﬂuoranthene ions. AGC target for precursor
ions was 1 × 106 with maximum injection time 1 s. AGC target
for ﬂuoranthene ions was 1 × 106 (maximum inject time 1 s).
Precursor ions were activated for 30 ms. For all fragmentation
methods, isolation widths were 3 Th (m/z 1021.54 from liver),
7.5 Th (m/z 952.63 from brain), and 10 Th (m/z 1392.27 from
E. coli). MS/MS spectra were comprised of ﬁve microscans.
Data were recorded for 2−5 min in each case.
Data were analyzed using either Xcalibur version 2.1.0.1139
or 3.0.63 software.
■ DATA ANALYSIS
Visualization of FAIMS Data. Data were converted from
Thermo.raw format to mzML using msconvert as part of
ProteoWizard25 and then to imzML using imzMLConverter.26
Data in the imzML format were then loaded into MATLAB
(version 2013, The MathWorks Inc., Natick, Massachusetts)
using imzMLConverter and in-house software.
Total Ion Transmission Maps. A linear m/z axis was
generated between m/z 500 and 2000 with a step interval of
0.5. Generation of total ion transmission maps were performed
by sequentially loading in each spectrum from the 2D FAIMS
analysis, summing all data points that fell between adjacent
intervals on the linear m/z axis and inserting into a 2D matrix
(m × n, where m is number of scans in the 2D FAIMS analysis
and n is number of m/z bins on the generated m/z axis).
Isolation and display of a single DF value was performed by
extracting the relevant scans from the full data matrix and
normalizing to CF.
Single Ion Transmission Maps. Selected m/z values (with
user deﬁned tolerance) from the 2D FAIMS analysis were
loaded into an array. Generation of single ion transmission
maps was performed by selecting scans from each DF value,
and projecting signal intensities of the selected m/z into a 2D
matrix (m × n, where m is the CF (normalized to scan number)
and n is the DF). The 2D matrix was displayed in false color
normalized to the maximum intensity of the ion.
Software for generation of total ion transmission maps and
single ion transmission maps, together with a step-by-step
guide, is available for download from http://www.biosciences-
labs.bham.ac.uk/cooper/software.html.
Analysis of MS/MS Data. All mass spectra were
deconvoluted using the Xtract function in Xcalibur in order
to obtain monoisotopic masses. Mass spectra were processed
with a signal-to-noise ratio threshold of three. The processed
fragment ion list was submitted to Prosight PTM 2.0 (https://
prosightptm2.northwestern.edu) and searched against the
mouse or E. coli K-12 database accordingly, allowing all
modiﬁcations, with a fragment tolerance of 10 ppm. Identity
was conﬁrmed by manual analysis using Protein Prospector
(http://prospector.ucsf.edu/prospector/mshome.htm).
■ RESULTS AND DISCUSSION
The miniaturized chip-based ultraFAIMS device was coupled
with the orbitrap mass spectrometer and the Triversa
Nanomate, see Supporting Information, Figure 1. LESA
FAIMS mass spectrometry analyses, in which both the
dispersion ﬁeld (DF) and the compensation ﬁeld (CF) were
varied (2D FAIMS analysis), were performed on thin tissue
sections from mouse liver and mouse brain and on E. coli
growing on agar. Optimal DF and CF conditions for the
transmission of a particular species of interest were determined
and static FAIMS analyses, at a single DF and single CF setting,
were conducted. Static FAIMS analyses were coupled with
tandem mass spectrometry for protein identiﬁcation.
The transmission eﬃciency through the ultraFAIMS device is
illustrated in Supporting Information, Figure 2. The ﬁgure
shows single scan mass spectra of substance P and ubiquitin
following direct infusion electrospray of a peptide/protein
mixture (i.e., no LESA). In each case, the top mass spectrum
was recorded in the absence of the FAIMS device, the middle
Figure 1. LESA 2D-FAIMS mass spectrometry of mouse liver. (A) Single scan mass spectrum at DF = 130 Td, CF = 0.93 Td; (B) Single scan mass
spectrum at DF = 270 Td, CF = 2.68 Td; (C) Single scan mass spectrum recorded in the absence of FAIMS ﬁeld; (D) Mass spectrum recorded in
the absence of FAIMS ﬁeld comprising 37 coadded scans (∼1 min data).
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mass spectrum was recorded with the FAIMS device coupled
but with no ﬁeld applied, and the bottom mass spectrum was
recorded at the optimum FAIMS conditions for the ions of
interest. The results show that, while there is a drop in
sensitivity (∼1 order of magnitude) as a result of coupling the
FAIMS device, once coupled, the transmission eﬃciency
(FAIMS ﬁeld applied vs FAIMS no ﬁeld) is ∼80%. Moreover,
with FAIMS ﬁeld applied the signal-to-noise improves ∼2-fold
and ∼14-fold for the monoisotopic peaks of substance P and
ubiquitin, respectively.
2D FAIMS Analyses. Incorporation of FAIMS into the
LESA workﬂow resulted in improved signal-to-noise for both
intact protein peaks and small singly charged species. Figure
1A,B shows mass spectra obtained during a 2-D sweep of
dispersion ﬁeld (DF) and compensation ﬁeld (CF) following
LESA sampling of thin tissue sections of mouse liver. Each mass
spectrum represents a single scan, that is, total MS analysis time
of 1.8 s. At DF = 130 Td and CF = 0.93 Td (Figure 1A), the
mass spectrum is dominated by peaks corresponding to singly
charged small molecules. The abundant peaks at m/z 534.29
and 496.34 correspond to lysophosphatidylcholine (lyso-PC)
16:0 [M + K]+ and [M + H]+ adducts, respectively. Abundant
peaks at m/z 796.52 and 758.57 correspond to phosphati-
dylcholine PC 34:2 [M + K]+ and [M + H]+ adducts,
respectively. At DF = 270 Td and CF = 2.68 Td, the mass
spectrum is dominated by peaks corresponding to intact
protein ions, notably α- and β-globin (∼15 and ∼16 kDa,
respectively) and fatty acid binding protein FABP1 (∼15 kDa;
see below). For comparison, a single scan mass spectrum in the
absence of FAIMS ﬁeld is shown in Figure 1C and a 1 min data
summation (37 scans) in Figure 1D. After coadding 37 scans,
the S/N of the peak at m/z 953 is 14. The same peak in the
single FAIMS MS spectrum (Figure 1B) has S/N of 50. Similar
results were obtained following LESA FAIMS analysis of mouse
brain and E. coli, see Supporting Information, Figures 3 and 4.
For the mouse brain sample, dominant peaks corresponding to
an unknown protein of ∼22 kDa were observed, including in
the absence of the FAIMS ﬁeld. Nevertheless, at certain FAIMS
parameters, for example, DF = 270 Td, CF = 3.32 Td
(Supporting Information, Figure 3A), 17 proteins in the
molecular weight range 1−9 kDa were observed.
The results obtained from a 2D FAIMS analysis inform on
the gas-phase separation achieved and the optimum FAIMS
conditions (DF and CF) for transmission of a particular
molecular ion. Figure 2 shows the total ion transmission maps
obtained from the LESA FAIMS analysis of mouse liver. The
distribution of observed m/z with compensation ﬁeld at each of
the dispersion ﬁelds is shown. As DF increases, greater
separation with CF is observed. Three notable regions emerge.
Consider the results at DF = 270 Td. In the region CF = 1.5−
3.5 Td and m/z ∼ 700−1500, proteins in the molecular weight
range 14−23 kDa are transmitted. (The mass spectrum shown
in Figure 1B corresponds to this region of the FAIMS space.) A
second cluster is apparent in the region CF = −0.5−1 Td and
m/z ∼800−1100, and a third in the region CF = −0.5−1 Td
and m/z ∼1400−1900. The species in these clusters
correspond to high molecular weight (unresolved) proteins,
see Supporting Information, Figure 5.
The separation of lower and higher molecular weight
proteins is in agreement with the work of Shvartsburg and
co-workers.27−29 Shvartsburg et al.27 showed that whereas
smaller proteins displayed type C behavior18 (i.e., ion mobility
decreases with electric ﬁeld strength), proteins with molecular
weight >30 kDa showed an increase in ion mobility with
electric ﬁeld strength (A- or B-type behavior18). This
observation was attributed to alignment of the protein dipole
for the larger proteins with the electric ﬁeld during the high
ﬁeld portion of the FAIMS cycle (generally, dipole moment
scales with protein size). As a result, the collision cross section
of the protein ion in the plane orthogonal to the dipole
moment, rather than the rotationally averaged collision cross
section, dictates the ion mobility. Further work28 suggested that
the minimum dipole moment required for alignment in any
ﬁeld was ∼450 D, corresponding to a protein of MW ∼30 kDa.
The hypothesis was validated using the ultrahigh ﬁeld FAIMS
devices used in the current work:29 Ubiquitin ions (∼8.6 kDa)
displayed C-type behavior, that is, did not align, whereas bovine
serum albumin (∼66 kDa) displayed A-type behavior, that is,
Figure 2. Total ion transmission maps obtained following LESA 2D FAIMS analyses of mouse liver.
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dipoles aligned. In the experiments described here, the high
ﬁeld portion of the FAIMS cycle (the dispersion ﬁeld) varies
between ∼30 kV/cm (130 Td) and ∼70 kV/cm (270 Td), and
dipole alignment of the higher molecular weight protein ions is
expected. That is, the improved signals observed here for
proteins are the result of the separation of higher molecular
weight A-type protein ions and the lower molecular weight C-
type protein ions.
The total ion transmission maps obtained following LESA
2D-FAIMS MS analyses of mouse brain and E. coli are shown in
Supporting Information, Figure 6. Similar trends were observed
in both cases. As discussed, this particular mouse brain sample
is dominated by the presence of an unknown protein of ∼22
kDa, and this feature is apparent in the total ion transmission
maps. Nevertheless, higher molecular weight proteins (∼30
kDa) were transmitted at lower compensation ﬁelds, whereas
lower molecular weight proteins (∼10 kDa) were transmitted
at higher compensation ﬁelds (see Supporting Information,
Figure 3). For all samples, the total ion transmission maps have
a striated appearance. These striations arise from the various
charge states of the proteins.
Figure 3 shows ion transmission maps for speciﬁc m/z values.
Figure 3A−C shows maps obtained following analysis of mouse
liver for m/z 758.57, 760.58, and 806.57 corresponding to
protonated lipids phosphatidylcholine PC(34:2), PC(34:1),
and PC(38:6), respectively. The results suggest that, for these
species, the optimum FAIMS parameters are dispersion ﬁelds of
150−170 Td and compensation ﬁelds between 0 and 1 Td. At
higher dispersion ﬁelds, the lipids are transmitted at higher
compensation ﬁelds.
Figure 3. Ion transmission maps for speciﬁc m/z following LESA 2D FAIMS analyses of mouse liver (A) m/z 758.57 ± 0.01 (PC(34:2) + H+); (B)
m/z 760.58 ± 0.01 (PC(34:1) + H+); (C) m/z 806.57 ± 0.01 (PC(38:6) + H+); (D) m/z 919.7 ± 1.0 (β-globin, +17 charge state); (E) m/z 882.7 ±
1.0 (α-globin, +17 charge state); (F) m/z 894.0 ± 1.0 (fatty acid binding protein FABP1, +16 charge state).
Figure 4. LESA FAIMS mass spectrometry of mouse brain: static FAIMS mode. (Top) LESA mass spectrum obtained in the absence of FAIMS
ﬁeld. (Bottom) LESA FAIMS mass spectrum obtained at DF = 270 Td, CF = 2.6 Td. Inset: Expanded m/z regions. Both mass spectra comprise 1
min of data.
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Figures 3D−F shows the transmission maps for three
proteins from mouse liver. Transmission maps for ions of
m/z 919.7, 882.7, and 894.0, corresponding to β-globin (+17
charge state), α-globin (+17 charge state), and liver fatty acid
binding protein FABP1 (+16 charge state), respectively, are
shown. The data show that for proteins α- and β-globin in the
17+ charge state, optimum transmission occurs at DF = 130 Td
and CF ∼ 0.65 Td. Similar conditions were optimal for FABP1
in the 16+ charge state.
Static FAIMS Analyses. Optimum CF and DF conditions
were identiﬁed for the maximum transmission (and separation)
of proteins of interest by interrogating the results of 2D FAIMS
analyses. These conditions were subsequently applied for static
FAIMS analyses. Figure 4 shows results obtained following
LESA of a mouse brain section in the absence of FAIMS ﬁeld
and in a static FAIMS analysis (DF = 270 Td, CF = 2.6 Td).
(Note, this sample is separate from that described above and is
not dominated by the 22 kDa protein.) Both mass spectra
represent 1 min of data collection (a total of 37 scans for the
non-FAIMS analysis and 23 scans with FAIMS applied).
Clearly, the LESA FAIMS mass spectrum is far richer in
information than the spectrum obtained without FAIMS. In
this example, the majority of the peaks in the non-FAIMS
spectrum correspond to α-globin and β-globin in charge states
+19 to +12, with an additional +9 peak at m/z 952.63, that is,
three proteins were detected. It may be that in this analysis a
blood vessel on the tissue surface was sampled. In contrast, the
FAIMS mass spectrum reveals peaks corresponding to
numerous protein species (total of 29 individual protein
masses) in the range ∼5 to ∼37 kDa in a range of charge states,
and the globins are not the most abundant species.
The use of static FAIMS conditions enables tandem mass
spectrometry of the intact proteins. Supporting Information,
Figure 7, shows LESA FAIMS MS/MS spectra for ions with
m/z 1021.54 (+14 charge state; DF = 130 Td, CF = 0.30 Td)
from mouse liver and m/z 952.63 (+9 charge state; DF = 270
Td, CF = 2.60 Td) from mouse brain. Note that static FAIMS
conditions are optimized for both maximum transmission and
separation of ions of interest from other species and, therefore,
depend on the complexity of the substrate. Thus, the optimum
CF and DF values diﬀer between the liver and brain samples
(and E. coli samples below). Collision-induced dissociation
(CID), higher energy collision dissociation (HCD), and
electron transfer dissociation (ETD) were performed. The
data were searched against a mouse protein database using the
Prosight software to obtain putative assignments. The fragment
ions were subsequently manually analyzed and protein
identiﬁcations conﬁrmed. The proteins were identiﬁed as liver
fatty acid binding protein (FABP1) and ubiquitin. A similar
analysis was performed on a protein from the E. coli sample.
Ions of m/z 1392.27 (+7 charge state; DF = 210 Td, CF = 1.65
Td) were selected for CID. The MS/MS spectrum and
fragment ion summary are shown in Supporting Information,
Figure 8. The protein was identiﬁed as acid stress chaperone
HdeA. This protein has not previously been identiﬁed following
LESA of E. coli colonies.
■ CONCLUSION
We have shown that high resolution LESA mass spectrometry
may be coupled with FAIMS for the analysis of intact proteins
from a range of biological substrates. The approach has been
demonstrated on thin tissue sections from liver and brain and
on bacterial colonies growing on agar. Improvements in S/N
were observed due to the separation of higher molecular weight
proteins and small singly charged species from proteins of
lower molecular weight. These improvements in S/N result in
shorter analysis times making FAIMS a potentially promising
approach for intact protein imaging by LESA.
Various operating modes are available. It is possible to
determine optimum FAIMS conditions through 2-D sweeps of
dispersion ﬁeld and compensation ﬁeld and visualization of
separation in the m/z/CF and in the DF/CF space. Optimum
conditions (DF and CF) can subsequently be utilized in static
FAIMS analysis which may be coupled with tandem mass
spectrometry (CID, HCD, or ETD) for protein identiﬁcation.
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